Dupixent® (dupilumab) Approved in China as the First-ever …
WEB14 hours ago · Dupixent is available in China in a 300 mg dose as a pre-filled syringe or pre-filled pen and is now available for COPD. Dupixent is intended for injection under the skin (subcutaneous...
Press Release: Dupixent approved in China as the first-ever
WEB14 hours ago · The National Medical Products Administration (NMPA) in China has approved Dupixent (dupilumab) as an add-on maintenance treatment for adults with uncontrolled chronic obstructive pulmonary...
Press Release: Dupixent approved in China as the first-ever …
WEB1 day ago · The National Medical Products Administration (NMPA) in China has approved Dupixent (dupilumab) as an add-on maintenance treatment for adults with uncontrolled chronic obstructive pulmonary...
Sanofi's Dupixent scores double COPD win in US, China
WEB9 hours ago · After a long road that included a three-month delay as the agency pushed for additional data, the US FDA has approved Sanofi and Regeneron's Dupixent (dupilumab) for COPD -- as has...
Regeneron, Sanofi Say Dupixent Approved In China To Treat …
WEB13 hours ago · (RTTNews) - Regeneron Pharmaceuticals, Inc. (REGN) and Sanofi (SNY) Friday said the National Medical Products Administration (NMPA) in China has approved Dupixent as an add-on maintenance...
Press Release: Dupixent approved in the US as the first-ever
WEBSep 27, 2013 · Following recent approvals in the EU and China, the US approval is based on two landmark phase 3 studies that showed Dupixent achieved significant reduction in exacerbations, and also showed improvements in lung function and health-related quality of life compared to placebo
Dupixent® (dupilumab) Approved in the U.S. as the First-ever …
WEB11 hours ago · Following recent approvals in the EU and China, the U.S. approval is based on two landmark Phase 3 trials that showed Dupixent achieved significant reduction in exacerbations, and also showed improvements in lung function and health-related quality of life compared to placebo
FDA Approves Dupilumab as First Biologic Treatment for COPD
WEB10 hours ago · Dupixent significantly reduced COPD exacerbations in second positive phase 3 trial, accelerating FDA submission and confirming potential to become first approved biologic for this serious...
Regeneron, Sanofi Get FDA OK for Dupixent to Treat COPD
WEB1 day ago · Regeneron and Sanofi on Friday said the green light covers Dupixent as an add-on maintenance treatment in certain adults with uncontrolled chronic obstructive pulmonary disease, or COPD, and...
Press Release: Dupixent approved in China as the first-ever …
WEB14 hours ago · The approval of Dupixent for COPD in China is critical, as it fills a gap in targeted therapy for the disease and provides clinicians with a new treatment approach. This offers new hope for COPD patients who remain inadequately controlled even after triple therapy, as well as those who care for them."
- Some results have been removed